Myovant Sciences Ltd
NYSE:MYOV
Balance Sheet
Balance Sheet Decomposition
Myovant Sciences Ltd
Current Assets | 386.6m |
Cash & Short-Term Investments | 274.4m |
Receivables | 44m |
Other Current Assets | 68.1m |
Non-Current Assets | 16.9m |
PP&E | 9.6m |
Other Non-Current Assets | 7.3m |
Current Liabilities | 245.8m |
Accounts Payable | 12.2m |
Accrued Liabilities | 90m |
Other Current Liabilities | 143.5m |
Non-Current Liabilities | 715.9m |
Long-Term Debt | 358.7m |
Other Non-Current Liabilities | 357.2m |
Balance Sheet
Myovant Sciences Ltd
Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
0
|
181
|
109
|
156
|
77
|
675
|
407
|
|
Cash Equivalents |
0
|
181
|
109
|
156
|
77
|
675
|
407
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
3
|
10
|
27
|
|
Total Receivables |
0
|
0
|
1
|
1
|
0
|
4
|
24
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
4
|
23
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
3
|
8
|
|
Other Current Assets |
0
|
3
|
5
|
10
|
8
|
14
|
22
|
|
Total Current Assets |
0
|
184
|
115
|
167
|
88
|
705
|
488
|
|
PP&E Net |
0
|
1
|
1
|
2
|
14
|
13
|
11
|
|
Other Long-Term Assets |
0
|
0
|
3
|
4
|
4
|
7
|
21
|
|
Total Assets |
0
N/A
|
185
N/A
|
119
-36%
|
173
+45%
|
106
-39%
|
725
+585%
|
520
-28%
|
|
Liabilities | ||||||||
Accounts Payable |
0
|
3
|
5
|
11
|
15
|
18
|
12
|
|
Accrued Liabilities |
0
|
12
|
31
|
55
|
31
|
46
|
71
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
6
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
3
|
2
|
0
|
40
|
217
|
167
|
|
Total Current Liabilities |
0
|
18
|
37
|
72
|
86
|
281
|
250
|
|
Long-Term Debt |
0
|
0
|
44
|
93
|
114
|
359
|
359
|
|
Other Liabilities |
0
|
0
|
1
|
3
|
15
|
439
|
384
|
|
Total Liabilities |
0
N/A
|
19
+9 150%
|
81
+340%
|
169
+107%
|
214
+27%
|
1 079
+404%
|
993
-8%
|
|
Equity | ||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
2
|
85
|
229
|
502
|
791
|
1 046
|
1 252
|
|
Additional Paid In Capital |
1
|
252
|
266
|
506
|
684
|
710
|
796
|
|
Other Equity |
0
|
0
|
0
|
1
|
2
|
17
|
17
|
|
Total Equity |
0
N/A
|
167
N/A
|
38
-77%
|
4
-89%
|
108
N/A
|
354
-227%
|
473
-34%
|
|
Total Liabilities & Equity |
0
N/A
|
185
N/A
|
119
-36%
|
173
+45%
|
106
-39%
|
725
+585%
|
520
-28%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
37
|
60
|
61
|
72
|
90
|
91
|
95
|